Biblio

33557 resultats trouvés
Filtres: Filter is   [Clear All Filters]
S
Rofes A, Mandonnet E, Godden J, Baron MHelene, Colle H, Darlix A, de Aguiar V, Duffau H, Herbet G, Klein M et al..  2017.  Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol. ACTA NEUROCHIRURGICA. 159:1167-1178.
Mandonnet E, Wager M, Almairac F, Baron M-H, Blonski M, Freyschlag CF, Barone F, Fontaine D, Pallud J, Hegi M et al..  2017.  Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step? NEURO-ONCOLOGY PRACTICE. 4:241-247.
Zhou Y, Ravey A, Pera M-C.  2019.  A survey on driving prediction techniques for predictive energy management of plug-in hybrid electric vehicles. JOURNAL OF POWER SOURCES. 412:480-495.
Bakiri M, Guyeux C, Couchot J-F, Oudjida AKamel.  2018.  Survey on hardware implementation of random number generators on FPGA: Theory and experimental analyses. COMPUTER SCIENCE REVIEW. 27:135-153.
Raad J, Bertaux A, Cruz C.  2015.  A Survey on How to Cross-Reference Web Information Sources. 2015 SCIENCE AND INFORMATION CONFERENCE (SAI). :609-618.
Martin N, Bremaud N, Blanc J, Bertaut A, Brune L, Favier L.  2019.  Survey on medical treatments and symptoms of patients with cancer undergoing palliative treatment with home medical care followed at Georges-Francois-Leclerc cancer centre in Dijon (France). MEDECINE PALLIATIVE. 18:279-286.
Rousset A, Herrmann B, Lang C, Philippe L.  2014.  A Survey on Parallel and Distributed Multi-Agent Systems. EURO-PAR 2014: PARALLEL PROCESSING WORKSHOPS, PT I. 8805:371-382.
Becherif M.  2019.  Survey on Passivity Based Control of Induction Machine. ASIAN JOURNAL OF CONTROL. 21:2137-2154.
Dzviga C, Matevi C, Bonniaud P, Lavaud F, Girodet B, Birnbaum J, Lambert C, Hypersen IGrp Insect, Educ FFed Contin.  2016.  Survey on practice of venom immunotherapy in France. ARCHIVES OF MEDICAL SCIENCE. 12:150-155.
Boualouache A, Senouci S-M, Moussaoui S.  2018.  A Survey on Pseudonym Changing Strategies for Vehicular Ad-Hoc Networks. IEEE COMMUNICATIONS SURVEYS AND TUTORIALS. 20:770-790.
Lateef F, Ruichek Y.  2019.  Survey on semantic segmentation using deep learning techniques. NEUROCOMPUTING. 338:321-348.
Maerevoet M, Zijlstra JM, Follows G, Casasnovas R-O, Vermaat J.SP, Kalakonda N, Goy A, Choquet S, Van Den Neste E, Hill B et al..  2021.  Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study. JOURNAL OF HEMATOLOGY & ONCOLOGY. 14:111.
Reygaerts T, Arnaud L, Devilliers H.  2016.  Survival analysis is preferable to a count of events when assessing the effects of tobacco exposure in systemic lupus erythematosus: comment on the article by Montes et al. ARTHRITIS & RHEUMATOLOGY. 68:1046-1047.
Arnaud L, Devilliers H, Amoura Z.  2014.  Survival analysis versus event count. ANNALS OF THE RHEUMATIC DISEASES. 73:e37.
Pokeerbux M.R, Giovannelli J., Dauchet L., Mouthon L., Agard C., Lega J.C, Allanore Y., Jego P., Bienvenu B., Berthier S. et al..  2019.  Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature. ARTHRITIS RESEARCH & THERAPY. 21:86.
Ducassou A., Murraciole X., Chaltiel L., Bolle S., Claude L., Coche-Dequeant B., Alapetite C., Supiot S., Huchet A., Bernier V. et al..  2015.  SURVIVAL AND PROGNOSTIC FACTORS IN 211 INTRACRANIAL EPENDYMOMAS-13 YEARS EXPERIENCE OF CHILD'S CANCER FRENCH SOCIETY. PEDIATRIC BLOOD & CANCER. 62:S214.
Bonnet C., Millot I, Achouba A., Czekala M., Chauny J., Thonnelier C., Husson-Robert B., Cottin Y..  2015.  SURVIVAL AND REHOSPITALIZATION AFTER A FIRST HOSPITALIZATION FOR HEART FAILURE: A NATIONWIDE POPULATION-BASED COHORT STUDY USING THE FRENCH EGB DATABASE. VALUE IN HEALTH. 18:A340.
Augustin A, Le Gouill S, Gressin R, Bertaut A, Monnereau A, Woronoff A-S, Tretarre B, Delafosse P, Troussard X, Moreau A et al..  2018.  Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 144:629-635.
Bonvalot S., Gaignard E., Stoeckle E., Meeus P., Decanter G., Carrere S., Honore C., Delhorme J.B, Fau M., Tzanis D. et al..  2019.  Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database. ANNALS OF SURGICAL ONCOLOGY. 26:2286-2293.
Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadie M, Monnereau A, Osca-Gelis G et al..  2014.  Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. LANCET ONCOLOGY. 15:931-942.
Houvenaeghel G, Classe JMarc, Garbay J-R, Giard S, Cohen M, Faure C, Charytansky H, Rouzier R, Darai E, Hudry D et al..  2016.  Survival impact and predictive factors of axillary recurrence after sentinel biopsy. EUROPEAN JOURNAL OF CANCER. 58:73-82.
Pons-Tostivint E, Kirova Y, Lusque A, Campone M, Geffrelot J, Mazouni C, Mailliez A, Pasquier D, Madranges N, Firmin N et al..  2019.  Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis. ANNALS OF SURGICAL ONCOLOGY. 26:356-365.
Bonvalot S, Gaignard E, Stoeckle E, Honore C, Meeus P, Penel N, Ferron G, Firmin N, Duffaud F, Di Marco A et al..  2018.  Survival impact of surgical management in reference centers for retroperitoneal sarcoma: A nationwide study of FSG-GETO and NETSARC.. JOURNAL OF CLINICAL ONCOLOGY. 36
Minniti D., Fernandez-Trincado J.G, Smith L.C, Lucas P.W, Gomez M., Pullen J.B.  2021.  Survival in an extreme environment: Which is the closest globular cluster to the Galactic centre? ASTRONOMY & ASTROPHYSICS. 648:A86.
Simon J, Chaix M, Billa O, Kamga AMamguem, Roignot P, Ladoire S, Coutant C, Arveux P, Quantin C, Dabakuyo-Yonli TSandrine.  2020.  Survival in patients with HR+/HER2-metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study. BRITISH JOURNAL OF CANCER. 123:1071-1077.

Pages